Complaint procedures are deficient in that they do not include provisions that allow for the review and determination of an investigation by the quality control unit.
Inspection Record
Newton Laboratories, Inc. — FDA 483 Findings
Inspectors Martin M Kimani · John D McintoshThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Container closure systems do not provide adequate protection against foreseeable external factors in storage and use that can cause deterioration or contamination of the drug product.
The written stability testing program is not followed.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- Novel Laboratories, Inc. d.b.a LUPIN2020-11-05 · US FDASimilar to finding 3 The written stability program is not followed.
- Wells Pharmacy Inc.2025-04-25 · US FDASimilar to finding 2 Container closure systems do not provide adequate protection against foreseeable external factors in storage and use that can cause deterioration or…
- SAFC Pharma Carlsbad2017-06-22 · US FDASimilar to finding 2 Container closure systems do not provide adequate protection against foreseeable external factors in storage and use that can cause deterioration or…
- H & P Industries, Inc.2015-07-11 · US FDASimilar to finding 3 The written stability testing program is not followed.
- Edge Pharma, LLC2021-11-30 · US FDASimilar to finding 3 The written stability testing program is not followed.
A record as of the US FDA document published on 2026-10-22. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.